✦ LIBER ✦

Novel Therapies for the Mucopolysaccharidoses that Target Inflammation & Impact Skeletal Disease

✍ Scribed by Calogera Simonaro; Edward Schuchman

Book ID: 116989636
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 60 KB
Volume: 105
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2011.11.150

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Novel Use for Acid Ceramidase in Cell-

A Novel Use for Acid Ceramidase in Cell-Based Therapies For Degenerative Joint Diseases, Including the Mucopolysaccharidoses

✍ Edward Schuchman; Sylvain Sachot; Mark Haskins; Calogera Simonaro 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Mechanisms of Disease: cancer targeting

Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy

✍ Drosten, Matthias; Pützer, Brigitte M 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 347 KB

MP6-06 POPULATION-LEVEL TRENDS IN THE AD

MP6-06 POPULATION-LEVEL TRENDS IN THE ADOPTION OF NOVEL TARGETED AGENTS FOR SYSTEMIC THERAPY AND IMPACT ON RATES OF CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA

✍ Psutka, Sarah; Kim, Simon; Gross, Cary; Van Houten, Holly; Thompson, R. Houston; 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 48 KB

[ACS Symposium Series] Galectins and Dis

[ACS Symposium Series] Galectins and Disease Implications for Targeted Therapeutics Volume 1115 || Translational Rational for the Clinical Development of OTX-008: A Novel Drug That Inhibits Galectin-1 Expression in Human Cancer Models

✍ Klyosov, Anatole A.; Traber, Peter G. 📂 Article 📅 2012 🏛 American Chemical Society ⚖ 244 KB